Cannabinoid CB2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injury.
Baty
Darric E
DE
Department of Neurosurgery, Temple University Hospital, Philadelphia, Pennsylvania, USA.
Zhang
Ming
M
Li
Hongbo
H
Erb
Carolyn J
CJ
Adler
Martin W
MW
Ganea
Doina
D
Loftus
Christopher M
CM
Jallo
Jack I
JI
Tuma
Ronald F
RF
D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects* / Q000503:physiopathology*; D005260:Female; D007274:Injections, Intraperitoneal; D008124:Locomotion / Q000187:drug effects* / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D011292:Premedication; D043885:Receptor, Cannabinoid, CB2 / Q000819:agonists* / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013119:Spinal Cord Injuries / Q000235:genetics* / Q000503:physiopathology; D015854:Up-Regulation / Q000235:genetics; D001743:Urinary Bladder / Q000294:innervation
D043885:Receptor, Cannabinoid, CB2